Because MOTS-c enhances insulin-independent glucose uptake, patients with type 1 diabetes or those using exogenous insulin should be monitored carefully to prevent hypoglycemia, though this theoretical risk has not materialized in clinical reports to date
Yang F, Leung VY, Luk KD, Chan D, Cheung KM: Mesenchymal stem cells arrest intervertebral disc degeneration through chondrocytic differentiation and stimulation of endogenous cells
Ther Adv Chronic Dis (2021) 12_suppl:2040622321995691
pharmacodynamic overlap possible via shared antioxidant pathways Primary concern / IV glutathione and liver-enzyme monitoring in patients on dulaglutide Monitoring recommended / LFTs at baseline and periodically when adding high-dose IV glutathione Evidence gap / no randomized controlled trial has tested the combination directly GLP-1 antioxidant effect / dulaglutide independently reduces oxidative stress markers in human studies Key guideline / ADA Standards of Care 2024 does not list glutathione as contraindicated with GLP-1 agents Bottom line / low-dose oral glutathione appears safe
Strikingly, it was observed that the FIXgla-Fas/HEK293 reporter cells must be maintained in the warfarin-containing medium, as the residual vitamin K in the cell culture medium was suitably sufficient to stimulate apoptosis of the reporter cells, even without antibody incubation
